Magno Revenue

About Magno

Magno is a company that serves as a bridge between the Israeli and American health-tech markets. We specialize in identifying and promoting technological solutions, products, and knowledge in the healthcare industry with a significant potential for integration into the US market. With our expertise and collaborations with valued partners in the US, we empower start-up companies and provide investors and businesses with exceptional opportunities. At Magno, we work in partnership with Tara Group, a leading organization in the world of health systems strategy and research in Israel. Our team leverages the cutting-edge methodology and experience of Tara to adapt and promote Israeli health-tech and med-tech innovation in the American market. Why Magno: • Unique methodology: Our proprietary methodology is based on our extensive experience working with industry and technology companies in the US, allowing us to identify the chances of success of Israeli companies in the US market and address their challenges. • Experienced Team: Our team consists of experts in the health and tech fields, including Oved Yehezkel, Co-founder and Chairman, Noam Yarimi, CEO, Nir Lempart, Advisory Board Chairman, and top health consultants and experts in Israel and internationally. • Strong partnerships: We have established partnerships with 8200 Bio Forum, a US medical organization from California, and Mayo Clinic, providing us with access to local medical services and knowledge of the US reimbursement system. • Outstanding outcomes: In our first year of activity, we examined 150 companies and only signed with 4, demonstrating our ability to identify and pursue only the best opportunities. Join us in our mission to seek out unmet needs and opportunities in the constantly evolving US health market. Our workflow is designed to uncover promising start-up ventures with significant commercial growth potential, and an investment in Magno guarantees shares in these ventures.

View contact profiles from Magno